Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
I’m a freelance journalist based in San Francisco. Before going freelance, I was MIT Technology Review’s material science editor; and I graduated from MIT’s Science Writing program in 2004.
Dark-field x-ray imaging could make for more-accurate mammograms and better security screens.
Nanoparticles allow researchers to initiate biochemical events at will.
Harvard researchers are developing the first drug that specifically targets cancer stem cells.
A leader in documenting man-made climate change, MIT’s Ronald Prinn has also made it his business to inform world leaders–and the public–about the risks of ignoring it.
Simple techniques yield complex compound.
Unifying algorithm for neural prosthetics will help convert brain signals into action.
A new nanoscale tool reveals strong electric fields inside cells.
Nanoparticles can be activated by radio frequencies.
Future diagnostic tests for cancer may probe cell stiffness.
New models of the human liver will help uncover toxicity problems before drugs reach the clinic.